Hypolipidemic drugs can change the composition of rat brain lipids.

  title={Hypolipidemic drugs can change the composition of rat brain lipids.},
  author={Marek Vecka and Eva Tvrzick{\'a} and Barbora Staňkov{\'a} and Franti{\vs}ek Nov{\'a}k and Olga N. Novakova and Ale{\vs} Ž{\'a}k},
  journal={The Tohoku journal of experimental medicine},
  volume={204 4},
Hypolipidemic drugs are potent serum cholesterol lowering agents used for prevention of coronary heart disease. In addition to their cholesterol lowering effect, these drugs exhibit both pleiotropic beneficial and various neurological side effects. Therefore, we analysed effect of the hypolipidemic drugs, fenofibrate and statins, on membrane lipid composition in the rat brain tissue. Male Wistar rats were given 0.1 mg of fenofibrate, lovastatin, pravastatin, fluvastatin or placebo (control… 

Tables from this paper

Lovastatin potentiates the antidepressant efficacy of fluoxetine in rats
Investigating the Effects of Statins on Cellular Lipid Metabolism Using a Yeast Expression System
Two significant phenomena are detected: first, cells treated with simvastatin develop an adaptive response compensating the lower activity of HMGR, and second, statins cause a substantial drop in the level of glycerophospholipids.
Fluvastatin alters psychomotor performance and daily activity but not the spatial memory in rats.
The results suggest that fluvastatin altered psychomotor performance and daily activity in rats, but it did not affect the spatial memory, which might be associated with alterations in the composition of the brain lipids caused by fluvASTatin.
Chronic Pravastatin but Not Atorvastatin Treatment Impairs Cognitive Function in Two Rodent Models of Learning and Memory
The data suggest that chronic treatment with pravastatin impairs working and recognition memory in rodents, and the reversibility of the effects on cessation of treatment is similar to what has been observed in patients, but the lack of effect of atorvostatin suggests that lipophilicity may not be a major factor influencing statin-induced cognitive impairments.
Simvastatin impairs spatial memory in rats at a specific dose level.
Investigation of the behavioral effects of long-term simvastatin application on daily activity, psychomotor performance and spatial memory using Sprague-Dawley rats revealed that simVastatin administration had no significant effect on daily action, and suggested that simvastsatin alters psychom motor behavior at higher nervous system levels.
Ameliorative Effect of Commiphora Myrrha Against Oxidative Stress Induced by High Fat Diet in Rats
CME had the ability to improve oxidative stress induced by HFD and the effect of Commiphora Myrrha resin ethanolic extract (CMEE) on renal MDA, glutathione reductase (GR) activity in kidney and histopathological alterations in renal tissue was estimated.
Neutral sphingomyelinase-2, acid sphingomyelinase, and ceramide levels in COPD patients compared to controls
Background Increased pulmonary ceramide levels are suggested to play a causative role in lung diseases including COPD. Neutral sphingomyelinase-2 (nSMase-2) and acid SMase (aSMase), which hydrolyze
Potential Anti-Dementia Agents in Traditional Chinese Medicine
It is indicated that TCM is not only a rich source of acetylcholinesterase inhibitors, but also of great potential to derive other kinds of anti-dementia agents which are either directly associated with ameliorating dementia or have complementary effects.


Statin effects on cholesterol micro-domains in brain plasma membranes.
Effect of hypolipidemic drugs on key enzyme activities related to lipid metabolism in normolipidemic rabbits.
Reduction in levels of 24S-hydroxycholesterol by statin treatment in patients with Alzheimer disease.
The effect of statins on LDL partially explains the reduction of plasma oxysterol level, and 3 statins and a nonstatin hypolipidemic agent on plasma levels of 24S-hydroxycholesterol and apo E in patients with AD are examined.
Mitochondrion is the principal target for nutritional and pharmacological control of triglyceride metabolism.
Reduction of plasma 24S-hydroxycholesterol (cerebrosterol) levels using high-dosage simvastatin in patients with hypercholesterolemia: evidence that simvastatin affects cholesterol metabolism in the human brain.
The greater reduction of plasma concentrations of 24S-hydroxycholesterol compared with cholesterol indicates that simvastatin in a dosage of 80 mg/d reduces cholesterol turnover in the brain.
Isoprenoids as mediators of the biological effects of statins.
  • J. Liao
  • Biology, Chemistry
    The Journal of clinical investigation
  • 2002
Evidence indicates that some of the cholesterol-independent, or so-called pleiotropic, effects of statins involve improving or restoring endothelial function, enhancing the stability of atherosclerotic plaques, decreasing oxidative stress and inflammation, and inhibiting the thrombogenic response in the vascular wall.
Lack of predictability of classical animal models for hypolipidemic activity: a good time for mice?
A review of clinical trials comparing HMG-CoA reductase inhibitors.
Although the currently available HMG-CoA reductase inhibitors differ in their relative hypolipidemic effects, as a class they constitute the most effective agents available to maximally reduce elevated concentrations of LDL-cholesterol.